REDWOOD CITY, Calif., Aug. 25, 2016 /PRNewswire/ -- Nevro Corp. (NYSE: NVRO), a global medical device company that is providinginnovative evidence-based solutions for the treatment of chronic pain, today announced that its management is scheduled to present at the following upcoming investor conferences:
Event: Wells Fargo 2016 Healthcare ConferenceLocation:
Event: Morgan Stanley Global Healthcare ConferenceLocation: New York City, NY at the Grand Hyatt New York HotelDate: Tuesday, September 13, 2016Time: 11:45 a.m. ET / 8:45 a.m. PT
Each presentation will be accessible via a live audio webcast, accessible in the "Investors" section of the company's website at: http://www.nevro.com/investors. Following each presentation, an archived copy will be available on the Investor Events and Presentations webpage of the Company's website.
Headquartered in Redwood City, California, Nevro is a global medical device company focused on providing innovative products that improve the quality of life of patients suffering from debilitating chronic pain. Nevro has developed and commercialized the Senza spinal cord stimulation (SCS) system, an evidence-based neuromodulation platform for the treatment of chronic pain. The Senza system is the only SCS system that delivers Nevro's proprietary HF10 therapy. Senza, HF10, Nevro and the Nevro logo are trademarks of Nevro.
Investor Relations Contact:Nevro Investor RelationsKatherine Bock(650) email@example.com
To view the original version on PR Newswire, visit:http://www.prnewswire.com/news-releases/nevro-to-present-at-upcoming-investor-conferences-300318420.html
SOURCE Nevro Corp.
Subscribe to our Free Newsletters!
Systemic Lupus Erythematosus (SLE) is an autoimmune disease that affects multiple organs like the ...
The Hib vaccine protects children against infections like meningitis and pneumonia that are caused ...
Dysthymia or persistent depressive disorder (PDD) is a chronic low mood and self-esteem affecting ...View All